| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Operating expenses: | ||||||||
Research and development | ||||||||
70,261 | 57,943 | 48,022 | 36,511 | 27,169 | 21,062 | 0 | 0 | 0 |
General and administrative | ||||||||
56,024 | 19,781 | 16,116 | 11,616 | 7,676 | 4,578 | 0 | 0 | 0 |
Total operating expenses | ||||||||
126,285 | 77,724 | 64,138 | 48,127 | 34,845 | 25,640 | 0 | 0 | 0 |
Loss from operations | ||||||||
-126,285 | -77,724 | -64,138 | -48,127 | -34,845 | -25,640 | 0 | 0 | 0 |
Other income, net | ||||||||
6,983 | 5,593 | 3,948 | 2,423 | 1,246 | 855 | 0 | 0 | 0 |
Net loss | ||||||||
-119,302 | -72,131 | -57,169 | -41,723 | 0 | - | 0 | 0 | - |
Other comprehensive income: | ||||||||
Unrealized loss on marketable securities | ||||||||
0 | - | 0 | 0 | - | - | - | - | - |
Comprehensive loss | ||||||||
-119,347 | -71,860 | -59,869 | -45,359 | -33,599 | -24,785 | 0 | 0 | 0 |
Net loss per share, basic and diluted | ||||||||
-1.69 | 2.31 | -0.63 | -0.70 | -3.97 | -2.64 | -1.77 | -1.49 | -1.41 |
Weighted-average common shares outstanding, basic and diluted | ||||||||
35,919 | 36,293 | 32,312 | 24,479 | 3,413 | 3,410 | 3,394 | 3,380 | 3,368 |